Cleared Traditional

K871912 - PV-LAB

K871912 is the FDA 510(k) clearance for PV-LAB by Electro-Diagnostic Instruments. It is a Class 2 Cardiovascular device (product code DPT) cleared through the Traditional 510(k) pathway after a 276-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1988
Decision
276d
Days
Class 2
Risk

K871912 is an FDA 510(k) clearance for the PV-LAB, MODEL PVL-1, PERIPHERAL VASCULAR SYSTEM. Classified as Probe, Blood-flow, Extravascular (product code DPT), Class II - Special Controls.

Submitted by Electro-Diagnostic Instruments (Burbank, US). The FDA issued a Cleared decision on February 18, 1988 after a review of 276 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2120 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Electro-Diagnostic Instruments devices

Submission Details

510(k) Number K871912 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 1987
Decision Date February 18, 1988
Days to Decision 276 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
151d slower than avg
Panel avg: 125d · This submission: 276d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DPT Probe, Blood-flow, Extravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPT Probe, Blood-flow, Extravascular

All 13
Devices cleared under the same product code (DPT) and FDA review panel - the closest regulatory comparables to K871912.
ACCUCOM 2
K874138 · Datascope Corp. · Jun 1988
SSH-160A ULTRASONIC PULSED ECHO IMAGING SYSTEM
K875266 · Toshiba Medical Systems · Apr 1988
HIGH FREQ LINEAR ARRAY(HFLA)SCANHEAD W/DPLR SIDEAR
K872441 · Advanced Technology Laboratories, Inc. · Feb 1988
INTRAVASCULAR CATHETER W/DOPPLER TRANSDUCER
K860121 · NuMED, Inc. · Jun 1986